S'abonner

Health trajectories in older patients hospitalized for COVID-19: Results from the GeroCovid multicenter study - 30/12/22

Doi : 10.1016/j.rmed.2022.107088 
Caterina Trevisan a, b, Francesco Tonarelli c, Alberto Zucchelli d, Ilaria Parrotta e, , Riccardo Calvani f, Alba Malara k, Fabio Monzani h, Pietro Gareri i, Gianluca Zia j, Raffaele Antonelli Incalzi g

the GeroCovid Acute Wards Working Group

a Department of Medical Science, University of Ferrara, Ferrara, Italy 
b Geriatrics Division, Department of Medicine (DIMED), University of Padua, Italy 
c Geriatric Intensive Care Unit, Department of Experimental and Clinical Medicine, University of Florence, Italy 
d Department of Information Engineering, University of Brescia, Brescia, Italy 
e Movement Control and Neuroplasticity Research Group, Tervuursevest 101, 3001, Leuven, Belgium 
f Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy 
g Unit of Geriatrics, Department of Medicine, Campus Bio-Medico University and Teaching Hospital, Rome, Italy 
h Scuola di Specializzazione in Geriatria e Gerontologia Università di Pisa UOC Geriatria, Universitaria Azienda Ospedaliero-Universitaria Pisana, Italy 
i Geriatra ASP Catanzaro CDCD Catanzaro Lido, Italy 
j Bluecomapanion, LTD, Italy 
k Presidente Fondazione ANASTE-HUMANITAS, Responsabile Scientifico European Confederation of Care-Home Organisations (E.C.H.O.), Associazione Nazionale Strutture Territoriali (ANASTE) Calabria A full list of the working group members is provided in Supplementary material – Appendix 1, Italy 

Corresponding author.

Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.

Connectez-vous pour en bénéficier!

Abstract

Background

COVID-19 has disproportionately affected older adults. Yet, healthcare trajectories experienced by older persons hospitalized for COVID-19 have not been investigated. This study aimed at estimating the probabilities of transitions between severity states in older adults admitted in COVID-19 acute wards and at identifying the factors associated with such dynamics.

Methods

COVID-19 patients aged ≥60 years hospitalized between March and December 2020 were involved in the multicentre GeroCovid project–acute wards substudy. Sociodemographic and health data were obtained from medical records. Clinical states during hospitalization were categorized on a seven-category scale, ranging from hospital discharge to death. Based on the transitions between these states, first, we defined patients’ clinical course as positive (only improvements), negative (only worsening), or fluctuating (both improvements and worsening). Second, we focused on the single transitions between clinical states and estimated their probability (through multistage Markov modeling) and associated factors (with proportional intensity models).

Results

Of the 1024 included patients (mean age 78.1 years, 51.1% women), 637 (62.2%) had a positive, 66 (6.4%) had a fluctuating, and 321 (31.3%) had a negative clinical course. Patients with a fluctuating clinical course were younger, had better mobility and cognitive levels, fewer diseases, but a higher prevalence of cardiovascular disease and obesity. Considering the single transitions, the probability that older COVID-19 patients experienced clinical changes was higher within a 10-day timeframe, especially for milder clinical states. Older age, male sex, lower mobility level, multimorbidity, and hospitalization during the COVID-19 first wave (compared with the second one) were associated with an increased probability of progressing towards worse clinical states or with a lower recovery.

Conclusion

COVID-19 in older inpatients has a complex and dynamic clinical course. Identifying individuals more likely to experience a fluctuating clinical course and sudden worsening may help organize healthcare resources and clinical management across settings at different care intensity levels.

Le texte complet de cet article est disponible en PDF.

Keywords : Aged, Health transitions, Trajectories, COVID-19


Plan


© 2022  Elsevier Ltd. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 206

Article 107088- janvier 2023 Retour au numéro
Article précédent Article précédent
  • Association of serum CC16 levels with eosinophilic inflammation and respiratory dysfunction in severe asthma
  • Houman Goudarzi, Hirokazu Kimura, Hiroki Kimura, Hironi Makita, Michiko Takimoto-Sato, Yuki Abe, Akira Oguma, Munehiro Matsumoto, Nozomu Takei, Machiko Matsumoto-Sasaki, Kaoruko Shimizu, Masaru Suzuki, Noriharu Shijubo, Shau-ku Huang, Nobuyuki Hizawa, Masaharu Nishimura, Satoshi Konno
| Article suivant Article suivant
  • Effect of chemotherapy, immunotherapy, and targeted therapies on removal of indwelling pleural catheters in non-small cell lung cancer patients with malignant pleural effusions
  • Melissa Wang, Kaitlin Sparrow, Chrystal Chan, Ashley Gillson, Daniel Stollery, Pen Li

Bienvenue sur EM-consulte, la référence des professionnels de santé.

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.